CN102898520B - 抗ctnnb1单克隆抗体3f9及其用途 - Google Patents
抗ctnnb1单克隆抗体3f9及其用途 Download PDFInfo
- Publication number
- CN102898520B CN102898520B CN201210444185.6A CN201210444185A CN102898520B CN 102898520 B CN102898520 B CN 102898520B CN 201210444185 A CN201210444185 A CN 201210444185A CN 102898520 B CN102898520 B CN 102898520B
- Authority
- CN
- China
- Prior art keywords
- catenin
- monoclonal antibody
- application
- chip
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210444185.6A CN102898520B (zh) | 2012-11-08 | 2012-11-08 | 抗ctnnb1单克隆抗体3f9及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210444185.6A CN102898520B (zh) | 2012-11-08 | 2012-11-08 | 抗ctnnb1单克隆抗体3f9及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102898520A CN102898520A (zh) | 2013-01-30 |
CN102898520B true CN102898520B (zh) | 2014-05-07 |
Family
ID=47571035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210444185.6A Active CN102898520B (zh) | 2012-11-08 | 2012-11-08 | 抗ctnnb1单克隆抗体3f9及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102898520B (zh) |
-
2012
- 2012-11-08 CN CN201210444185.6A patent/CN102898520B/zh active Active
Non-Patent Citations (8)
Title |
---|
Amy V. Gerstein 等.APC/CTNNB1 (β-Catenin) Pathway Alterations in Human Prostate Cancers.《GENES, CHROMOSOMES & CANCER》.2002,第34卷9-16. |
Amy V. Gerstein 等.APC/CTNNB1 (β-Catenin) Pathway Alterations in Human Prostate Cancers.《GENES, CHROMOSOMES & * |
CANCER》.2002,第34卷9-16. * |
Cytochemistry》.2007,第55卷(第9期),963-974. * |
Jennifer L. Herington等.β-Catenin (CTNNB1) in the Mouse Uterus During Decidualization and the Potential Role of Two Pathways in Regulating Its Degradation.《Journal of Histochemistry & Cytochemistry》.2007,第55卷(第9期),963-974. |
Jennifer L. Herington等.β-Catenin (CTNNB1) in the Mouse Uterus During Decidualization and the Potential Role of Two Pathways in Regulating Its Degradation.《Journal of Histochemistry & * |
β-连环素与原发性肝癌术后复发和转移的相关性;张志强 等;《世界华人消化杂志》;20120628;第20卷(第18期);1662-1666 * |
张志强 等.β-连环素与原发性肝癌术后复发和转移的相关性.《世界华人消化杂志》.2012,第20卷(第18期),1662-1666. |
Also Published As
Publication number | Publication date |
---|---|
CN102898520A (zh) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9429577B2 (en) | Anti-uroplakin II antibodies systems and methods | |
CN106978400A (zh) | 抗pd‑l1蛋白单克隆抗体及其用途 | |
CN102827281B (zh) | 抗cd2蛋白单克隆抗体及其用途 | |
CN102924594B (zh) | 抗肿瘤蛋白p63单克隆抗体及其用途 | |
CN105238762A (zh) | 抗pd-1蛋白单克隆抗体杂交瘤细胞及其产生的抗pd-1单克隆抗体和应用 | |
CN105254759A (zh) | 抗cd56蛋白单克隆抗体杂交瘤细胞及其产生的抗cd56单克隆抗体和应用 | |
CN105131114A (zh) | 抗p16蛋白单克隆抗体杂交瘤细胞及其产生的抗p16单克隆抗体和应用 | |
CN106188292B (zh) | 抗cd4蛋白单克隆抗体及其用途 | |
CN103102414B (zh) | 抗her2蛋白单克隆抗体及其用途 | |
CN102786595B (zh) | 抗cd5蛋白单克隆抗体及其用途 | |
CN110357964A (zh) | 抗cd31蛋白单克隆抗体及其用途 | |
CN105175543A (zh) | 抗E-Cadherin蛋白单克隆抗体杂交瘤细胞及其产生的抗E-Cadherin单克隆抗体和应用 | |
CN102898520B (zh) | 抗ctnnb1单克隆抗体3f9及其用途 | |
CN102827278B (zh) | 抗肿瘤蛋白p53单克隆抗体及其用途 | |
CN105622751B (zh) | 抗Ki67蛋白单克隆抗体及其用途 | |
CN102911271B (zh) | 抗ctnnb1单克隆抗体12h7及其用途 | |
CN109021102A (zh) | 抗sma蛋白单克隆抗体及其用途 | |
CN106749668A (zh) | 抗ido1蛋白单克隆抗体及其用途 | |
CN109096400A (zh) | 抗pdpn蛋白单克隆抗体及其用途 | |
CN107446046A (zh) | 抗cd20蛋白单克隆抗体及其用途 | |
CN107266572A (zh) | 抗pd‑l1蛋白单克隆抗体及其用途 | |
CN106977605A (zh) | 抗cd19蛋白单克隆抗体及其用途 | |
CN106188288B (zh) | 抗s100p蛋白单克隆抗体及其用途 | |
CN105237638A (zh) | 抗egfr蛋白单克隆抗体杂交瘤细胞及其产生的抗egfr单克隆抗体和应用 | |
CN106854245A (zh) | 抗cd30蛋白单克隆抗体及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160414 Address after: 100176 Beijing City, Changping District small town life Zhongguancun Life Science Park Road No. 8 School District No. 11 Building 2 layer Patentee after: GENETRON HEALTH (BEIJING) Co.,Ltd. Address before: 214092, Jiangsu province Wuxi Binhu District Mashan biological medicine outsourcing Area No. 7, building two, 2 floor Patentee before: WUXI ORIGENE BIO-TECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220110 Address after: 214000, floor 5, No. 1719-15, Huishan Avenue, Huishan Economic Development Zone, Wuxi City, Jiangsu Province Patentee after: Wuxi fanshengzi Biotechnology Co.,Ltd. Patentee after: GENETRON HEALTH (BEIJING) Co.,Ltd. Address before: 100176 floor 2, building 11, yard 1, No. 8, Life Science Park, Zhongguancun, Huilongguan town, Changping District, Beijing Patentee before: GENETRON HEALTH (BEIJING) Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Anti CTNNB1 monoclonal antibody 3F9 and its use Effective date of registration: 20230316 Granted publication date: 20140507 Pledgee: Agricultural Bank of China Limited by Share Ltd. Wuxi Huishan branch Pledgor: Wuxi fanshengzi Biotechnology Co.,Ltd. Registration number: Y2023980035046 |